Jianmin Pharmaceutical Group Co (SHSE:600976) FFO


SHSE:600976 Jianmin Pharmaceutical Group Co Ltd SHSE:600976
59 GF Score
Price ¥27.81
GF Value ¥41.67
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jianmin Pharmaceutical Group Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:600976
59GF Score
Jianmin Pharmaceutical Group Co Ltd SHSE:600976
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jianmin Pharmaceutical Group Co (SHSE:600976) Overvalued in 2026?

Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥27.81 is trading 33.3% below its estimated GF Value™ of ¥41.67. GuruFocus considers Jianmin Pharmaceutical Group Co to be Significantly Undervalued.

Key valuation signals for SHSE:600976:

  • FFO:
  • GF Value™: ¥41.67 vs. price of ¥27.81 (33.3% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600976 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jianmin Pharmaceutical Group Co Business Description

Address No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
59GF Score

Get the complete analysis for SHSE:600976

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.81
Price
¥41.67
GF Value